Nkarta (NKTX) Common Equity (2019 - 2026)
Nkarta's Common Equity was $247.74 million in Q2 2026, down 30.7% from $357.67 million a year earlier and down 13.3% from the prior quarter.
Powered by 
Analysis
Nkarta (NKTX) Common Equity (2019 - 2026) Analysis & Trends
At the end of FY2025, Common Equity at Nkarta came in at $312.33 million, down 23.4% from FY2024.
- Common Equity shows a five-year compound annual growth rate of -0.6% (FY2020 to FY2025).
- In earlier years, Common Equity was $407.98 million in FY2024 (+49.3%), $273.29 million in FY2023 (-26.6%), $372.21 million in FY2022 (+48.3%) and $250.97 million in FY2021 (-21.9%).
- The Q2 2026 figure marks the lowest quarterly Common Equity since Q1 2022.
- Compared with a year earlier, Common Equity has declined for six straight quarters, with an average decline of 5.9% over the last eight quarters.
- The best year-over-year quarter for Common Equity over five years was Q1 2023 (growth of 51.6%); the worst was Q2 2026 (a decline of 30.7%).
- Per Business Quant data, NKTX's Common Equity in the three quarters before Q2 2026 was $285.86 million (Q1 2026), $312.33 million (Q4 2025) and $337.9 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 44.95 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 51.81 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 89.30 Bn |
| 10 | Nkarta | 96.80 Mn | -1.37 Bn | - | 215.75 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 215.75 Mn |
| Jun 30, 2026 | 247.74 Mn |
| Mar 31, 2026 | 285.86 Mn |
| Dec 31, 2025 | 312.33 Mn |
| Sep 30, 2025 | 337.90 Mn |
| Jun 30, 2025 | 357.67 Mn |
| Mar 31, 2025 | 378.81 Mn |
| Dec 31, 2024 | 407.98 Mn |
| Sep 30, 2024 | 430.87 Mn |
| Jun 30, 2024 | 453.18 Mn |
| Mar 31, 2024 | 473.65 Mn |
| Dec 31, 2023 | 273.29 Mn |
| Sep 30, 2023 | 296.82 Mn |
| Jun 30, 2023 | 317.98 Mn |
| Mar 31, 2023 | 346.65 Mn |
| Dec 31, 2022 | 372.21 Mn |
| Sep 30, 2022 | 399.26 Mn |
| Jun 30, 2022 | 421.04 Mn |
| Mar 31, 2022 | 228.71 Mn |
| Dec 31, 2021 | 250.97 Mn |
API Access
Nkarta Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=NKTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "NKTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=NKTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();